Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study.

Henry David Jeffry HoggKatie BrittainDawn TeareJames TalksKonstantinos BalaskasPearse KeaneGregory Maniatopoulos

Published in: BMJ open (2023)

NHS Research Ethics Committee and UK Health Research Authority approvals are in place (21/NW/0138). Informed consent is planned for interview participants only. Written and oral dissemination is planned to public, clinical, academic and commercial stakeholders.

Keyphrases

age related macular degeneration
artificial intelligence
big data
machine learning
healthcare
deep learning
public health
randomized controlled trial
primary care
patient safety
decision making